Stem definition | Drug id | CAS RN |
---|---|---|
3032 | 97-18-7 |
None
None
None
None
None
None
None
Source | Code | Description |
---|---|---|
ATC | D10AB01 | DERMATOLOGICALS ANTI-ACNE PREPARATIONS ANTI-ACNE PREPARATIONS FOR TOPICAL USE Preparations containing sulfur |
ATC | P02BX01 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS ANTHELMINTICS ANTITREMATODALS Other antitrematodal agents |
CHEBI has role | CHEBI:35684 | antiplatyhelmintic drugs |
CHEBI has role | CHEBI:86328 | anti-fungal agrichemical |
MeSH PA | D000871 | Anthelmintics |
MeSH PA | D000890 | Anti-Infective Agents |
MeSH PA | D000891 | Anti-Infective Agents, Local |
MeSH PA | D000977 | Antiparasitic Agents |
MeSH PA | D000980 | Antiplatyhelmintic Agents |
None
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 4.75 | acidic |
pKa2 | 7.52 | acidic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Mu-type opioid receptor | GPCR | Ki | 5.65 | DRUG MATRIX | |||||
Adenosine receptor A2a | GPCR | Ki | 6.18 | DRUG MATRIX | |||||
Alpha-2A adrenergic receptor | GPCR | Ki | 5.84 | DRUG MATRIX | |||||
Sodium-dependent noradrenaline transporter | Transporter | Ki | 5.91 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 1A | GPCR | Ki | 5.50 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 2B | GPCR | Ki | 5.37 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 2C | GPCR | Ki | 5.34 | DRUG MATRIX | |||||
Alpha-2B adrenergic receptor | GPCR | Ki | 6.25 | DRUG MATRIX | |||||
D(3) dopamine receptor | GPCR | Ki | 5.84 | DRUG MATRIX | |||||
Alpha-2C adrenergic receptor | GPCR | Ki | 6.20 | DRUG MATRIX | |||||
Sodium-dependent dopamine transporter | Transporter | Ki | 5.76 | DRUG MATRIX | |||||
Adenosine receptor A3 | GPCR | Ki | 6.33 | DRUG MATRIX | |||||
Transthyretin | Secreted | Kd | 7.21 | CHEMBL | |||||
Estrogen receptor | Nuclear hormone receptor | IC50 | 5.40 | CHEMBL | |||||
Estrogen receptor beta | Nuclear hormone receptor | IC50 | 5.09 | CHEMBL | |||||
Epidermal growth factor receptor | Kinase | IC50 | 6.21 | DRUG MATRIX | |||||
Tyrosine-protein kinase Lck | Kinase | IC50 | 5.65 | DRUG MATRIX | |||||
Receptor tyrosine-protein kinase erbB-2 | Kinase | IC50 | 5.67 | DRUG MATRIX | |||||
Thromboxane-A synthase | Enzyme | IC50 | 5.74 | DRUG MATRIX | |||||
Mitogen-activated protein kinase 14 | Kinase | IC50 | 6.50 | DRUG MATRIX | |||||
Solute carrier family 22 member 1 | Transporter | IC50 | 5.41 | CHEMBL | |||||
Substance-K receptor | GPCR | Ki | 5.81 | DRUG MATRIX | |||||
Mitogen-activated protein kinase 1 | Kinase | IC50 | 6.42 | DRUG MATRIX | |||||
Solute carrier family 22 member 2 | Transporter | IC50 | 5.72 | CHEMBL | |||||
Multidrug and toxin extrusion protein 1 | Transporter | IC50 | 5.28 | CHEMBL | |||||
Multidrug and toxin extrusion protein 2 | Transporter | IC50 | 5.18 | CHEMBL | |||||
Solute carrier family 22 member 3 | Transporter | IC50 | 5.26 | CHEMBL | |||||
N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D | Unclassified | INHIBITOR | IC50 | 4.97 | IUPHAR | ||||
Sodium/potassium-transporting ATPase subunit alpha-2 | Ion channel | IC50 | 5.30 | DRUG MATRIX | |||||
5-hydroxytryptamine receptor 1A | GPCR | IC50 | 5.26 | CHEMBL | |||||
M1-family alanyl aminopeptidase | Enzyme | IC50 | 4.37 | CHEMBL | |||||
Envelope glycoprotein gp160 | Viral envelope protein | IC50 | 5.21 | CHEMBL | |||||
Potassium channel subfamily T member 1 | Ion channel | ACTIVATOR | EC50 | 6 | IUPHAR | ||||
Envelope glycoprotein gp160 [Cleaved into: Surface protein gp120 | Unclassified | IC50 | 5.21 | CHEMBL |
ID | Source |
---|---|
D00802 | KEGG_DRUG |
C0005661 | UMLSCUI |
CHEBI:3131 | CHEBI |
CHEMBL290106 | ChEMBL_ID |
DB04813 | DRUGBANK_ID |
D001735 | MESH_DESCRIPTOR_UI |
2406 | PUBCHEM_CID |
2338 | IUPHAR_LIGAND_ID |
201 | INN_ID |
AMT77LS62O | UNII |
002972 | NDDF |
10016008 | SNOMEDCT_US |
None